By John Kennedy ( December 1, 2015, 2:50 PM EST) -- Aerie Pharmaceuticals Inc. on Monday fired back at a putative class action brought by investors who say the company misled them into thinking its top drug would perform better in clinical trials, telling a New Jersey federal court that the suit is based on "unfounded speculation" and "makes no sense."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.